Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer (Q38335084)

2 September 2017

Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer (English)

1 reference

2 September 2017

0 references

Sarah De Val

1

1 reference

2 September 2017

Joshua P Anderson

2

1 reference

2 September 2017

Analeah B Heidt

3

1 reference

2 September 2017

Dustin Khiem

4

1 reference

2 September 2017

Shan-Mei Xu

5

1 reference

2 September 2017

Brian L Black

6

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

2 September 2017

Developmental Biology

1 reference

2 September 2017

275

1 reference

2 September 2017

2

1 reference

2 September 2017

424-434

1 reference

Basic local alignment search tool

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Intussusceptive angiogenesis--the alternative to capillary sprouting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Role of the Ets transcription factors in the regulation of the vascular-specific Tie2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells. Association with the activated phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Molecular mechanisms of vasculogenesis and embryonic angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Specificity within the ets family of transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Role of ets factors in the activity and endothelial cell specificity of the mouse Tie gene promoter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

The Ets family contains transcriptional activators and repressors involved in angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Multiple PU.1 sites cooperate in the regulation of p40(phox) transcription during granulocytic differentiation of myeloid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Expression and function of Ets transcription factors in mammalian development: a regulatory network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

VISTA : visualizing global DNA sequence alignments of arbitrary length

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Multiple Ets factors and interferon regulatory factor-4 modulate CD68 expression in a cell type-specific manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Transcriptional regulation of vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Characterization of NERF, a novel transcription factor related to the Ets factor ELF-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Transcriptional programs regulating vascular smooth muscle cell development and differentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Vasculogenesis and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Role of ETS family transcription factors in vascular development and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

The ETS-domain transcription factor family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

The ETS-domain transcription factor family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Early expression of the different isoforms of the myocyte enhancer factor-2 (MEF2) protein in myogenic as well as non-myogenic cell lineages during mouse embryogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

When Ets transcription factors meet their partners

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

The Ets family member Erg gene is expressed in mesodermal tissues and neural crests at fundamental steps during mouse embryogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

A cAMP response element and an Ets motif are involved in the transcriptional regulation of flt-1 tyrosine kinase (vascular endothelial growth factor receptor 1) gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

Mutation of MEF2A in an inherited disorder with features of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.08.016

10.1016/J.YDBIO.2004.08.016

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference